Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Melatonin and steroid-dependent carcinomas.

J M Oosthuizen1, M S Bornman, H C Barnard

  • 1Department of Physiology, University of the Orange Free State, Bloemfontein, South Africa.

Andrologia
|September 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The prognostic relevance of full-thickness burns on ABSI.

Burns : journal of the International Society for Burn Injuries·2024
Same author

Supporting patients with heart failure with digital therapeutics-A pilot study in Germany.

Digital health·2022
Same author

EDCs and male urogenital cancers.

Advances in pharmacology (San Diego, Calif.)·2021
Same author

Depressive symptoms, impaired glucose metabolism, high visceral fat, and high systolic blood pressure in a subgroup of women with recent gestational diabetes.

Journal of psychiatric research·2017
Same author

Physical fitness and plasma leptin in women with recent gestational diabetes.

PloS one·2017
Same author

First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same journal

Correction.

Andrologia·2023
Same journal

The combination of ginger and zinc supplement could improve lead-induced reproductive dysfunction by inhibiting apoptosis mediated by oxidative damage and inflammation.

Andrologia·2022
Same journal

Testosterone and lifespan in males: At the right time and the right level.

Andrologia·2022
Same journal

CORRIGENDUM.

Andrologia·2022
Same journal

CORRIGENDUM.

Andrologia·2022
Same journal

Microfluidic devices employing chemo- and thermotaxis for sperm selection can improve sperm parameters and function in patients with high DNA fragmentation.

Andrologia·2022
See all related articles

Plasma melatonin levels were lower in breast cancer patients and higher in prostate cancer patients compared to controls. This suggests low melatonin may be linked to breast cancer risk.

Area of Science:

  • Endocrinology
  • Oncology
  • Biochemistry

Background:

  • Melatonin is a hormone with potential oncostatic properties.
  • Disruptions in melatonin secretion are observed in various cancers.
  • Plasma melatonin levels in cancer patients require further investigation.

Purpose of the Study:

  • To compare plasma melatonin concentrations in patients with breast or prostate carcinoma versus healthy controls.
  • To investigate the potential role of melatonin levels in the pathogenesis of these cancers.

Main Methods:

  • Blood samples were collected from patients diagnosed with breast or prostate carcinoma and control subjects.
  • Plasma melatonin concentrations were quantified using a validated assay.
  • Statistical analysis was performed to compare melatonin levels between groups.

Related Experiment Videos

Main Results:

  • Mean plasma melatonin was significantly lower in breast carcinoma patients compared to controls (p < 0.005).
  • Mean plasma melatonin was significantly higher in prostate carcinoma patients compared to controls (p < 0.005).

Conclusions:

  • Low plasma melatonin levels may be associated with an increased risk or presence of breast carcinoma.
  • Elevated plasma melatonin levels in prostate carcinoma patients warrant further research into its role.
  • Melatonin's differential association with breast and prostate cancer suggests distinct pathophysiological mechanisms.